Jump to Navigation

Facebook Connect

User login

 

 

 

 

Overview

Download Program Now

We invite you to attend the Spring Clinical Lipid Update (CLU) taking place February 24–26, 2017, at the Hyatt Regency Phoenix. Earn up to 28+ hours of continuing medical education when attending the CLU, additional courses, and symposia. Meet the experts in clinical lipidology, network with colleagues, and learn about the latest developments in the field. Hear the latest on new paradigms for cardiovascular prevention, unusual lipid disorders, the role of lipid management in autoimmune disorders, and much more!

We look forward to seeing you in Phoenix!

Airline Discount
Book your airfare on Delta a receive up to 5% off your flight to Phoenix. Book your flight through delta.com and enter NMPCX in the "offer code" box when searching for your flight. Discount is applicable for travel to and from Phoenix between February 19 - March 2, 2017.

Agenda


Friday, February 24, 2017

Session I: Lipids Across the Lifetime
3:40- 3:55 PM
Chapter Presidents Welcome & Introduction
3:55- 4:00 PM
ARS Questions
4:00- 4:30 PM
New Paradigms for Cardiovascular Prevention
Jennifer G. Robinson, MD, MPH, FNLA
4:30- 5:00 PM
Screening in Children and Young Adults age 20- 35- Where are we going?
Don P. Wilson, MD, FNLA
5:00- 5:30 PM
Lipid Treatment in the Older Adult
Antonio M. Gotto, Jr., MD, FNLA
5:30- 6:00 PM
ARS Questions and Q&A Panel
6:00- 7:00 PM
Welcome Reception in Exhibit Hall

Saturday, February 25, 2017

7:00- 7:50 AM
Breakfast in Exhibit Hall
7:50- 8:00 AM
Housekeeping Notes & ARS Questions for Session II
Session II: Lp(a)
8:00- 8:30 AM
Science Behind Interventions
Patrick M. Moriarty, MD, FNLA
8:30- 9:00 AM
Management Options and Interventions for Elevated Lipoprotein(a)
Harold E. Bays, MD, FNLA
9:00- 9:20 AM
ARS Questions and Q&A Panel
9:20- 9:50 AM
Break in Exhibit Hall
Session III: Difficult Case Presentations
9:50- 10:00 AM
ARS Questions for Session III
10:00- 10:30 AM
Patient with Lp(a) Disease Progression
P. Barton Duell, MD, FNLA
10:30- 11:00 AM
Patient with Atherosclerosis and no Obvious Risk Factors
Michael D. Shapiro, DO, FNLA
11:00- 11:30 AM
30-Year-old Patient with low HDL-C and Strong Family History
Benjamin J. Ansell, MD, FNLA
11:30- 12:00
ARS Questions and Q&A Panel
12:00- 12:15 PM
Chapter News & Notes
12:15- 1:15 PM
Lunch in Exhibit Hall
Session IV: Autoimmune Disorders
1:15- 1:20 PM
ARS Questions
1:20- 1:50 PM
The Role of Lipid Management in CV Risk Management with Rheumatic Disorders
Kathleen L. Wyne, MD, PhD, FNLA
1:50- 2:20 PM
Team Based Approach to Cardiovascular Risk Reduction in the Patient with Rheumatic Disorders
Elizabeth J. Jackson, MSN, CLS, FNLA and Carol Kirkpatrick, PhD, RDN, MPH, CLS, FNLA
2:20- 2:50 PM
The Role of Lipid Management in CV Risk Management in Patients with HIV
Karen E. Aspry, MD, MS, FNLA
2:50- 3:20 PM
ARS Questions and Q&A Panel
3:20- 3:45 PM
Break
Session V: Unusual Lipid Disorders
3:45- 3:50 PM
ARS Questions
3:50- 4:20 PM
"Cream of Tomato Soup" Blood: What's the Skinny on FCS and Other Severe Lipemias?
Eliot A. Brinton, MD, FNLA
4:20- 4:50 PM
Lipodystrophy
Yehuda Handelsman, MD, FNLA
4:50- 5:20 PM
Familial Combined Hyperlipidemia
Sergio Fazio, MD, PhD, FNLA
5:20- 5:45 PM
ARS Questions and Q&A Panel
6:15- 9:00 PM
Foundation of the National Lipid Association Event

Sunday, February 26, 2017

7:00- 7:50 AM
Breakfast
7:50- 8:00 AM
Housekeeping Notes & ARS Questions for Session VI
Session VI: Treatment of Diabetes- Role of Lipidologist in Treatment of Type 1 & 2 Diabetes
8:00- 8:30 AM
Bariatric Surgery: What a Lipidologist needs to know
Harold E. Bays, MD, FNLA
8:30- 9:00 AM
Contemporary Metabolic Surgery and Cardiovascular Risk
Sean P. Heffron, MD, MS, MSc
9:00- 9:30 AM
The Role of New Diabetes treatment in CV Risk Reduction
Arthur Schwartzbard, MD
9:30- 10:00 AM
ARS Questions and Q&A Panel
10:00- 10:30 AM
Management of Drug- Drug Interaction with Statins
Joseph J. Saseen, PharmD, CLS, FNLA
10:30- 11:00 AM
Lipid Management in the Heart Transplant Patient
Clay A. Cauthen, MA, MD
11:00- 11:15 AM
ARS Questions and Q&A Panel
11:15-
Adjourn

The NLA invites speakers and guests to provide scientific medical opinion, which do not necessarily reflect the policy of the NLA. The schedule and faculty are subject to change.

Faculty


Joyce L. Ross, MSN, ANP, CLS, CRNP, FPCNA, FNLA

Program Chair
President, National Lipid Association
Consultative Education Specialist,
  Cardiovascular Risk Intervention
University of Pennsylvania Health System- Retired
Philadelphia, PA

James A. Underberg, MD, MS, FNLA

Program Chair
President- Elect, National Lipid Association
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for
Prevention of Cardiovascular Disease
Director, Bellevue Hospital Lipid Clinic
New York, NY
Diplomate, American Board of Clinical Lipidology

Christie M. Ballantyne, MD, FNLA

Professor of Medicine
Chief, Section of Cardiovascular Research
Director, Center for Cardiovascular Disease Prevention
Baylor College of Medicine
Houston, TX

Dave L. Dixon, PharmD, BCPS, CDE, AACC, FNLA

Associate Professor, Ambulatory Care
Vice-Chair of Clinical Services
Department of Pharmacotherapy and Outcomes Science
Virginia Commonwealth University
School of Pharmacy
Richmond, VA

Daniel A. Duprez, MD, PhD, FAHA, FACC, FESC, FASH, FNLA

Donald and Patricia Garofalo Chair in Preventive Cardiology
Professor of Medicine/Cardiology
Director Lipid Clinic
Director of Research of the Rasmussen Center for Cardiovascular Disease Prevention
Adjunct Professor Epidemiology and Community Health (School of Public Health)
Cardiovascular Division
University of Minnesota
Minneapolis, MN

Anne C. Goldberg, MD, FACP, FNLA

President, Foundation of the NLA
Professor of Medicine
Washington University School of Medicine
St. Louis, MO

Robert Greenfield, MD, FACC, FAHA, FNLA

University of California, Irvine
Memorial Health Care Hospitals
Orange Coast Memorial Hoag Hospital
Newport Beach Hoag Hospital
Irvine Fountain Valley Regional Medical Center
Fountain Valley, CA

Wahida Karmally, DrPH, RD, CDE, CLS, FNLA

Associate Research Scientist
Dean’s Faculty, College of Dental Medicine
Director of Nutrition
Irving Institute for Clinical and Translational Research
Columbia University
 New York, NY

Gay J. Meyers, PA-C, CLS

Adjunct Faculty
University of Utah School of Medicine
Canyons Health and Wellness Center
Sandy, UT

Geeta Sikand, MA, RD, CLS, FNLA

Associate Clinical Professor of Medicine, Cardiology
Director of Nutrition
University of California Irvine
Irvine, CA

Benjamin J. Ansell, MD, FNLA

Professor of Medicine Cardiology
UCLA
School of Medicine
Co-Director UCLA CHAMP Program
Los Angeles, CA

Karen E. Aspry, MD, MS, FNLA

Assistant Professor of Medicine (Clinical)
Department of Medicine
The Warren Alpert Medical School
Brown University
East Greenwich, RI

Harold E. Bays, MD, FNLA

Medical Director / President
Louisville Metabolic and Atherosclerosis Research Center
Louisville, KY

Eliot A. Brinton, MD, FNLA

President, Utah Lipid Center
Salt Lake City, UT

Clay A. Cauthen, MA, MD

Transplant Cardiologist
Seton Heart Institute
Austin, TX

P. Barton Duell, MD, FNLA

Director, Lipid Disorders Clinic and LDL Apheresis
Director, Lipid-Atherosclerosis Laboratory
Knight Cardiovascular Institute
Division of Endocrinology, Diabetes, and Clinical Nutrition
Oregon Health and Science University
Portland, OR

Sergio Fazio, MD, PhD, FNLA

William and Sonja Connor Chair of Preventive Cardiology
Professor of Medicine
Director of Preventive Cardiology
Knight Cardiovascular Institute
Oregon Health and Science University
Portland, OR

Antonio M. Gotto, Jr., MD, FNLA

Dean Emeritus and Co-Chairman
Board of Overseers
Lewis Thomas University
Professor Weill Cornell Medical College
New York, NY

Yehuda Handelsman, MD, FNLA

Medical Director & Principal Investigator,
Metabolic Institute of America
Tarzana CA

Sean P. Heffron, MD, MS, MSc

Instructor of Medicine,
NYU School of Medicine
New York, NY

Elizabeth J. Jackson, MSN, CNS, CLS, FNLA

Cardiovascular Clinical Nurse Specialist
Clinical Lipid Specialist
Cardio Texas
Austin, TX

Carol Kirkpatrick, PhD, RDN, MPH, CLS, FNLA

Wellness Center Director
Clinical Assistant Professor
Idaho State University
Pocatello, ID

Patrick M. Moriarty, MD, FNLA

Professor of Medicine
Director of Clinical Pharmacology
University of Kanas Medical Center
Kansas City, KS

Jennifer Robinson, MD, MPH, FNLA

Professor
Departments of Epidemiology & Medicine
University of Iowa
Iowa City Iowa, IA

Joseph J. Saseen, PharmD, CLS, FNLA

Professor
Clinical Pharmacy and Family Medicine
University of Colorado Denver
Anschutz Medical Campus
Aurora, CO

Arthur Schwartzbard, MD

Associate Professor
Department of Medicine
NYU Langone Medical Center
New York, NY

Michael D. Shapiro, DO, FNLA

Associate Professor of Medicine and Radiology
Director, Cardiac MR CT Program 
Knight Cardiovascular Institute   
Oregon Health & Science University
Portland, OR

Don P. Wilson, MD, FNLA

Endowed Chair
Cardiovascular Health and Risk Prevention
Pediatric Endocrinology and Diabetes
Cook Children’s Medical Center
Fort Worth, TX

Kathleen L. Wyne, MD, PhD, FNLA

Associate Professor of Clinical Medicine
Division of Endocrinology & Metabolism
The Ohio State University Wexner Medical Center
Columbus, OH

Featured Sessions


Click on the Presentation title to read a brief abstract.

Benjamin J. Ansell, MD, FNLA
Presentation: Low HDL Patient

Sergio Fazio, MD, PhD, FNLA
Presentation: Familial Combined Hyperlipidemia


Antonio M. Gotto, Jr., MD, FNLA
Presentation: Lipid Treatment in the Older Adult

Jennifer Robinson, MD, MPH, FNLA
Presentation: New Paradigms for Cardiovascular Prevention

Accreditation


CME credit provided by the National Lipid Association

Physicians
The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The National Lipid Association designates this live activity for a maximum of 13.50 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 13 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

CE credit provided by Postgraduate Institute for Medicine

Pharmacists
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Session I- Universal Activity Number 0809-9999-17-094-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 2.00 contact hour(s) (.20 CEUs) of the Accreditation Council for Pharmacy Education

Session II- Universal Activity Number 0809-9999-17-095-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.25 contact hour(s) (.125 CEUs) of the Accreditation Council for Pharmacy Education

Session III- Universal Activity Number 0809-9999-17-096-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 2.25 contact hour(s) (.225 CEUs) of the Accreditation Council for Pharmacy Education

Session IV – Universal Activity Number 0809-9999-17-097-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 2.00 contact hour(s) (.2 CEUs) of the Accreditation Council for Pharmacy Education

Session V– Universal Activity Number 0809-9999-17-098-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 2.00 contact hour(s) (.2 CEUs) of the Accreditation Council for Pharmacy Education

Session VI – Universal Activity Number 0809-9999-17-099-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 2.00 contact hour(s) (.2 CEUs) of the Accreditation Council for Pharmacy Education

Session VII – Universal Activity Number 0809-9999-17-108-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.25 contact hour(s) (.125 CEUs) of the Accreditation Council for Pharmacy Education

Nursing
This educational activity for 12.6 contact hours is provided by the Postgraduate Institute for Medicine.
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Session I- 2.0 credits; Session II- 1.3; Session III- 2.1 credits; Session IV- 2.0 credits; Session V- 2.0 credits; Session VI- 2.0 credits; Session VII- 1.2.

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

 

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses, and registered dietitians with an interest in lipid management.

Type of Activity
Live Activity
Knowledge

Educational Objectives
At the conclusion of this activity, all participants should be able to:
Session I: Lipids Across the Lifetime

  • Discuss the current ASCVD-risk screening recommendations and guidelines as they relate to all age groups.
  • Identify lipid-lowering therapeutic approaches for older adults.

Sessions II: Lp(a)

  • Evaluate the application of lipid and non-lipid biomarkers in cardiovascular risk detection.
  • Outline current and emerging pharmacologic therapies for patients with elevated levels of lipoprotein a. 

Sessions III: Difficult patient cases

  • Review representative clinical cases in the management of patients with dyslipidemia.

Sessions IV: Autoimmune Disorders

  • Identify appropriate dyslipidemia management strategies in patients with rheumatic disorders and HIV.

Sessions V: Unusual Lipid Disorders

  • Describe the mechanisms and manifestations of unusual genetic lipid disorders, including Familial Chylomicronemia Syndrome, Lipodystrophy, and Familial Combined Hyperlipidemia.
  • Identify effective treatment strategies for patients with unusual lipid disorders.

Session VI: Management of the Obese and Diabetic Patient: Bariatric Surgery and Risk Reduction

  • Identify combination therapies for the management of type 2 diabetes.   
  • Describe the pros and cons of bariatric surgery for the treatment of obesity.

Session VII: Approaches to Care

  • Review management options for drug-drug interactions in patients using combination therapies.
  • Identify specialized lipid management strategies for patients with a history of transplantation.

Pre-Conference Courses


The NLA’s Masters in Lipidology Course is an intensive 2-day training course offers an in-depth review of the core curriculum in Clinical Lipidology for health care professionals who desire to practice at an advanced level within the field. Learn from leading experts, assess your knowledge of lipid science and advance your personal standard of practice.
 

The NLA's Lipid Academy provides a comprehensive, in-depth indoctrination to lipid science and is open to all health care professionals interested in developing a core competency in the diagnosis and treatment of dyslipidemia. The interactive Lipid Academy course provides health professionals with the knowledge and tools necessary to work effectively in a lipid practice, and will serve as a preparatory course for the Annual Scientific Forum and other advanced lipid training.
 

Abstracts


Abstracts Coming Soon

This information is still being developed by our program developers. Please check back soon for updates to be posted as soon as they are available. Also, check for updates in your email. If you are not currently on our emal blast list and you would like to receive communications from and information about NLA programs, Click Here to sign up.

Foundation Event


Food on Foot Tasting Tour

Saturday, February 25
6:15 - 9:00 PM

Explore Phoenix one bite at a time! Put your walking shoes on and prepare for a night of sights, food, drinks and fun. The Food on Foot Tasting Tour event will take attendees to 4 different local restaurants to sample the food and to enjoy 2 complimentary drinks. Encourage your friends and colleagues to join you for this 3-hour event to support the Foundation of the National Lipid Association.


We will meet in the hotel lobby at 6:00 pm. 

$75/person
 

Symposia


Non-CME Events

 

Non-CME Dinner Symposium: Challenges in Prescribing PCSK9 Inhibitors

Jerome D. Cohen, MD, FACC, FAHA, FNLA

Terry A. Jacobson, MD, FACP, FAHA, FNLA

Kevin C. Maki, PhD, FNLA, CLS

Friday, February 24
7:00 – 9:00pm
Phoenix Ballroom

Sponsored by Amgen and Sanofi-Regeneron



Non-CME Breakfast Symposium: Challenging Cases and Treatment for Lysosomal Acid Lipase Deficiency

Don P. Wilson, MD, FNLA

Saturday, February 25
6:30 – 7:50am
Phoenix Ballroom

Sponsored by Alexion Pharmaceuticals

Expert Theaters


 

Repatha®(evolocumab): A Focused Clinical Review

 

Presented by Robert Lending, MD

Saturday, February 25th
12:15 - 1:15pm
Hyatt Regency Phoenix- Ellis Room West
Lunch will be served
 

Reduction in circulating levels of low‐density lipoprotein cholesterol (LDL‐C) remains fundamental to

major cholesterol treatment guidelines and recommendations. 1‐7 Nonetheless, despite available

treatment over 70% of patients with CHD in the United States did not achieve an LDL‐C level below 70

mg/dL.8 Patients with familial hypercholesterolemia (FH) may also require additional LDL‐C reduction.

This program will review a current therapy for additional LDL‐C lowering.

 

 

Sponsored by Amgen

Honors and Awards Ceremony


Honors and Awards Ceremony Coming Soon

This information is still being developed by our program developers. Please check back soon for updates to be posted as soon as they are available. Also, check for updates in your email. If you are not currently on our emal blast list and you would like to receive communications from and information about NLA programs, Click Here to sign up.

Mentoring Reception


Mentors and Mentees Coming Soon

This information is still being developed by our program developers. Please check back soon for updates to be posted as soon as they are available. Also, check for updates in your email. If you are not currently on our emal blast list and you would like to receive communications from and information about NLA programs, Click Here to sign up.

Mobile App


Coming Soon

Social Media


     

Support Recognition

American Board of Clinical Lipidology (ABCL)

The ABCL is an independent physician-certifying organization offering the highest benchmark of professional competency in Clinical Lipidology. Enhance your professional stature and credibility in the field, and demonstrate your commitment to the highest standards of patient care. The program is open to licensed physicians in the US and Canada.

Accreditation Council for Clinical Lipidology (ACCL)

The ACCL offers the Clinical Lipid Specialist (CLS) certification program to licensed physicians, nurses, nurse practitioners, physician assistants, pharmacists, registered dietitian/nutritionists, clinical exercise physiologists and other healthcare professionals who meet qualifying criteria. The CLS program certifies and validates one's professional credentials to provide specialized care to patients with dyslipidemia and related cardiometabolic conditions.

www.lipidspecialist.org

Aegerion Pharmaceuticals

Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The company has a diversified commercial portfolio of rare disease therapies which includes MYALEPT® and JUXTAPID®. Aegerion’s parent company, Novelion Therapeutics, seeks to advance its portfolio of rare disease therapies by investing in science and clinical development. Novelion is currently developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes. 

www.novelion.com

Akcea Therapeutics, a Subsidiary of Ionis Pharmaceuticals, Inc.

Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc., is a development and commercialization company focused on transforming serious cardiometabolic lipid disorders. Akcea’s portfolio spans multiple targets and disease states, including both rare and more common lipid disorders, using advanced RNA-targeted antisense therapeutics.

www.akceatx.com

Alexion

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders, including lysosomal acid lipase deficiency (LAL-D). Learn more at www.alexion.com 

Amarin

Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Vascepa® (icosapent ethyl), Amarin's first FDA approved product, is a highly-pure, EPA-only, omega-3 fatty acid product available by prescription. For more information about Vascepa visit www.vascepa.com. For more information visit www.amarincorp.com 

Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

www.amgen.com

Boston Heart Diagnostics

Boston Heart Diagnostics is transforming the treatment of cardiovascular disease by providing healthcare providers and their patients with novel, personalized diagnostics and integrated customized lifestyle programs that have the power to change the way clinicians and patients communicate about disease and improve heart health. Boston Heart looks beyond the “good” and “bad” cholesterol assessment that conventional labs provide to give a more complete picture of heart health.

www.BostonHeartDiagnostics.com

Kastle Therapeutics

Our Mission is to serve patients who have significant unmet medical needs and are underserved. To solve challenges for therapeutic developers and manufacturers. To support quality of care for patients with severe diseases. www.kastletherapeutics.com

Kowa Pharmaceuticals America, Inc.

Established in 2008, Kowa Pharmaceuticals America, Inc., is committed to developing and delivering safe, effective solutions in the field of cardiometabolic therapeutics. We do this by maintaining high ethical and professional standards--and it all starts with people. By empowering our employees to live this mission, we can create a healthier vision for the future.  www.kowapharma.com

Quest Diagnostics
Quest Diagnostics, the world’s leading provider of diagnostic testing, information and services, offers the Cardio IQ Solution—a comprehensive approach to heart health.  Visit 4myheart.com and QuestDiagnostics.com

Retrophin

Retrophin is a biopharmaceutical company dedicated to delivering life-changing therapies to people living with rare diseases who have few, if any, treatment options. http://www.retrophin.com/

Virtual Exhibit Hall


Virtual Exhibit Hall Coming Soon

This information is still being developed by our program developers. Please check back soon for updates to be posted as soon as they are available. Also, check for updates in your email. If you are not currently on our emal blast list and you would like to receive communications from and information about NLA programs, Click Here to sign up.

Industry Council


Akcea Therapeutics, A Subsidiary of Ionis Pharmaceuticals, Inc. 

Amgen

AstraZeneca LP

Kastle Therapeutics

Kowa Pharmaceuticals America 

Quest Diagnostics

Sanofi-Regeneron

Media Partners


Hyatt Regency Phoenix

Phoenix , AZ

Hyatt Regency Phoenix

122 North Second Street
Phoenix, AZ 85004

 

Meeting Room Rate: $229/night ++

Room Reservation Cutoff Date: January 27, 2017

For Reservations click here or call 1-888-421-1442  and ask for the National Lipid Association’s room rate. Reserve your room early for a discounted rate.
 

Experience the tranquil beauty of the Southwest combined with the  exhilarating energy of a vibrant cosmopolitan city at Hyatt Regency Phoenix. Situated in the center of downtown Phoenix, the hotel is adjacent to the Phoenix Convention Center and steps away from sports venues, dining and shopping.

 


Airline Discount
Book your airfare on Delta a receive up to 5% off your flight to Phoenix. Book your flight through delta.com and enter NMPCX in the "offer code" box when searching for your flight. Discount is applicable for travel to and from Phoenix between February 19 - March 2, 2017.

Local Attractions

Heritage Square
Heritage Square is located on Block 14 in the original townsite of Phoenix. Heritage Square dates back to the late 1800s. Whether you love history, technology, good food, or just a quiet place to reflect – a visit to Heritage Square is for you! These buildings typically date to the late 1800s and early 1900s, and many now house shops and restaurants.


Arizona Science Center
Arizona Science Center has a rich history of exploration, innovation and collaboration. The continued growth of the Center and its close connection with the Arizona community provides a unique experience for everyone it reaches. Using an informal, hands-on approach to science exploration and inspiration the Center has more than 164,000 square-feet of space, of which 98,000 is dedicated to the exploration for guests.


Desert Botanical Garden
For more than 70 years, the Desert Botanical Garden has been teaching and inspiring visitors from the local community and around the world, providing research, exhibits and more designed to help understand, protect and preserve the desert’s natural beauty. The Botanical Garden features 140 acres, 50,000+ plant displays and provides tours, trails and exhibits.


Camelback Mountain
Camelback Mountain, with an elevation of 2,704 feet, is an excellent hike or climb in Arizona. The hike is quick and Camelback Mountain is in the middle of the Phoenix Valley. There are two hiking trails with beautiful views!


Heard Museum
Dedicated to the sensitive and accurate portrayal of Native arts and cultures, the Heard Museum is an institution that successfully combines the stories of American Indian people from a personal perspective with the beauty of art. Partnerships with American Indian artists and tribal communities provide visitors with a distinctive perspective about the art and cultures of Native people, especially those from the Southwest.

Late Breakers

Coming soon...

Expert Theater

National Lipid Association attendees are passionate healthcare providers who expect high-quality and innovative education while attending the Spring Clinical Lipid Update. Add your presentation to their list of must-see events by signing up to host an Expert Theater in 2017.

Download Expert Theater Info Sheet

CME Symposia

The National Lipid Association (NLA) has established that independently developed CME/CE-certified satellite symposia held in conjunction with the scientific meetings of the NLA are valuable opportunities to provide continuing education for our members and meeting participants. In this regard, we are pleased to offer satellite symposia opportunities in conjunction with our 2017 Spring Clinical Lipid Update.

Satellite symposia curriculum include educational topics that complement or supplement the NLA scientific program agenda, addressing educational gaps that prevent optimal patient care.

The following guidelines provide important information regarding hosting a satellite symposium in conjunction with the 2017 Spring Clinical Lipid Update, including the proposal creation and application processes. Please contact the NLA Program Development department directly should there be any questions or further information required.

We hope to see you in Phoenix!  

Download Symposia Guidelines

Exhibit in Phoenix

Join us in Phoenix for the Spring Clinical Lipid Update on February 24 – 26, 2017 . This 2.5-day conference offers sponsors 4 dedicated exhibit hall hours and special exhibit hall events to meet with our 250+ attendees: Physicians (lipidologists, cardiologists, endocrinologists, primary care physicians), physician assistants, advanced practice nurses, pharmacists, and dietitians interested in not only the growing field of lipidology, but the overall reduction and prevention of cardiovascular events.

A message from our President, Joyce L. Ross, MSN, CRNP, CLS, FNLA

“It is my pleasure to invite you to join us as an exhibitor at our 2017 Clinical Lipid Updates. NLA meetings provide you with an opportunity to reach your target audience in a uniquely intimate educational setting. We are proud to showcase not only an agenda led by distinguished faculty who are leaders in their fields, but a lively exhibit hall to act as a home-base for our attendees. On behalf of our board of directors and the members we serve, we look forward to seeing you in 2017.”

Review the 2017 prospectus or contact us for more information on exclusive sponsorships, marketing opportunities, and more.

E: exhibits@lipid.org

P: 904-309-6205 

Registration: Registration and payment must be received no later than January 24, 2017 After this date, meeting materials and name badge cannot be guaranteed.

By registering for the 2017 NLA Spring Clinical Lipid Update, attendee understands and agrees that attendee’s name, city, and state may be shared with other attendees and exhibitors. By allowing an exhibitor to scan the conference badge, attendee understands, agrees and consents to the sharing of attendee’s contact information with the company that scanned the conference badge.

Cancellation: Telephone cancellations will not be accepted. A written notice of cancellation must be received no later than January 24, 2017. This includes social events and guest fees. There will be a $100 fee for all cancellations. There will be no refunds if cancelling within 30 days of the start of the meeting date.

by Dr. Radut.